ArticleRand health quarterly2025

Assessing Cumulative, Meaningful Benefits of Disease-Modifying Therapies Targeting Synucleinopathies: Conference Proceedings and Roadmap for Research.

Claire E O'Hanlon et al.PubMed ↗Full text ↗

No numbers read from the abstract.